Targeting quiescent tumor cells via oxygen and IGF-I supplementation

Cancer Research

Volumn 72, Issue 3, 2012, Pages 801-809

  Kyle, Alastair H ^a   Baker, Jennifer H E ^a   Minchinton, Andrew I ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; INSULIN; OXYGEN; PACLITAXEL; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATMOSPHERIC PRESSURE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL HYPOXIA; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG TARGETING; FEMALE; HYPERBARIC OXYGEN; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MULTIPLE CYCLE TREATMENT; NONHUMAN; OXYGEN BREATHING; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; TISSUE CULTURE; TISSUE LEVEL; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL CULTURE TECHNIQUES; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; DEOXYCYTIDINE; DRUG SYNERGISM; HCT116 CELLS; HT29 CELLS; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, INBRED NOD; MICE, SCID; OXYGEN; PACLITAXEL; RECEPTOR, IGF TYPE 1; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84856557919     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-3059     Document Type: Article

References (41)

1. Rubin P, Casarett G. Microcirculation of tumors-Part I: Anatomy, function and necrosis. Clin Radiol 1966;17:220-9.
2. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955;9:539-49.
3. Brown JM. Evidence for acutely hypoxic cells inmouse tumours and a possible mechanism of reoxygenation. Br J Radiol 1979;52:650-6. (Pubitemid 9239867)
4. Durand RE, LePard NE. Contribution of transient blood flow to tumour hypoxia in mice. Acta Oncologica 1995;34:317-23.
5. Chaplin DJ, Durand RE, Olive PL. Acute hypoxia in tumour: Implications for modifiers of radiation effects. Int J Radiat Oncol Biol Phys 1986;12:1279-82. (Pubitemid 16030598)
6. Minchinton AI, Durand RE, Chaplin DJ. Intermittent blood flow in the KHT sarcoma-flow cytometry studies using Hoechst 33342. Br J Cancer 1990;62:195-200. (Pubitemid 20242434)
7. Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987;47:3039-51. (Pubitemid 17082621)
8. Jain RK. Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev 1997;26:71-90. (Pubitemid 27289526)
9. Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer 2006;6:583-92. (Pubitemid 44140857)
10. Sutherland RM. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 1988;240:177-84.
11. Tannock IF. Tumor physiology and drug resistance. Cancer Metastasis Rev 2001;20:123-32. (Pubitemid 34074688)
12. Krogh A. The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissue. J Physiol 1919;52:409-15.
13. Huxham LA, Kyle AH, Baker JH, Nykilchuk LK, Minchinton AI. Microregional effects of gemcitabine in HCT-116 xenografts. Cancer Res 2004;64:6537-41. (Pubitemid 39297911)
14. Sullivan RP, Mortimer G, Muircheartaigh IO. Cell proliferation in breast tumours: analysis of histological parameters Ki67 and PCNA expression. Ir J Med Sci 1993;162:343-7. (Pubitemid 23310941)
15. LaRue KE, Khalil M, Freyer JP. Microenvironmental regulation of proliferation in multicellular spheroids is mediated through differential expression of cyclin-dependent kinase inhibitors. Cancer Res 2004;64:1621-31. (Pubitemid 38428682)
16. Kyle AH, Huxham LA, Yeoman DM, Minchinton AI. Limited tissue penetration of taxanes: a mechanism for resistance in solid tumors. Clin Cancer Res 2007;13:2804-10. (Pubitemid 46788050)
17. Heys SD, Ogston K, Miller I, Hutcheon AW, Walker LG, Sarker TK, et al. Potentiation of the response to chemotherapy in patients with breast cancer by dietary supplementation with L-arginine: results of a randomised controlled trial. Int J Oncol 1998;12:221-5. (Pubitemid 28027250)
18. Lamb J, Wheatley DN. Single amino acid (arginine) deprivation induces G1 arrest associated with inhibition of cdk4 expression in cultured human diploid fibroblasts. Exp Cell Res 2000;255:238-49. (Pubitemid 30143857)
19. Tannock IF, Steele D, Roberts J. Influence of reduced concentration of L-glutamine on growth and viability of cells in monolayer, in spheroids, and in experimental tumours. Br J Cancer 1986;54:733-41. (Pubitemid 17177530)
20. Carlsson J, Stalnacke CG, Acker H, Haji-Karim M, Nilsson S, Larsson B. The influence of oxygen on viability and proliferation in cellular spheroids. Int J Radiat Oncol Biol Phys 1979;5:2011-20. (Pubitemid 10177998)
21. Hauptmann S, Gebauer-Hartung P, Leclere A, Denkert C, Pest S, Klosterhalfen B, et al. Induction of apoptosis in the centre of multicellular tumour spheroids of colorectal adenocarcinomas-involvement of CD95 pathway and differentiation. Apoptosis 1998;3:267-79. (Pubitemid 128691550)
22. Conte PF, Baldini E, Gardin G, Pronzato P, Amadori D, Carnino F, et al. Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO). Ann Oncol 1996;7:487-90. (Pubitemid 26232954)
23. Bontenbal M, van Putten WL, Burghouts JT, Baggen MG, Ras GJ, Stiegelis WF, et al. Value of estrogenic recruitment before chemotherapy: first randomized trial in primary breast cancer. J Clin Oncol 2000;18:734-42. (Pubitemid 30106603)
24. Paridaens R, Heuson JC, Julien JP, Veyret C, Van Zyl J, Klijn JG, et al. Assessment of estrogenic recruitment before chemotherapy in advanced breast cancer: a double-blind randomized study. European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group. J Clin Oncol 1993;11:1723-8. (Pubitemid 23277324)
25. Jiang Y, Pjesivac-Grbovic J, Cantrell C, Freyer JP. A multiscale model for avascular tumor growth. Biophys J 2005;89:3884-94. (Pubitemid 41725610)
26. Kyle AH, Huxham LA, Chiam AS, Sim DH, Minchinton AI. Direct assessment of drug penetration into tissue using a novel application of three-dimensional cell culture. Cancer Res 2004;64:6304-9. (Pubitemid 39129435)
27. van Tassel PV. A hyperbaric chamber for small animals. J Appl Physiol 1965;20:342-5.
28. Lund S, Flyvbjerg A, Holman GD, Larsen FS, Pedersen O, Schmitz O. Comparative effects of IGF-I and insulin on the glucose transporter system in rat muscle. Am J Physiol 1994;267:E461-6.
29. Schumacher R, Mosthaf L, Schlessinger J, Brandenburg D, Ullrich A. Insulin and insulin-like growth factor-1 binding specificity is determined by distinct regions of their cognate receptors. J Biol Chem 1991;266:19288-95. (Pubitemid 21908231)
30. Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoel MJ, Bertrand F, Cherqui G, Perret C, et al. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. Oncogene 2001;20:252-9. (Pubitemid 32150270)
31. Weinstein D, Simon M, Yehezkel E, Laron Z, Werner H. Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells. Diabetes Metab Res Rev 2009;25:41-9.
32. Bastian SE, Walton PE, Wallace JC, Ballard FJ. Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I) and an analogue LR3IGF-I in pregnant rats. J Endocrinol 1993;138:327-36. (Pubitemid 23300710)
33. Francis GL, Ross M, Ballard FJ, Milner SJ, Senn C, McNeil KA, et al. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. J Mol Endocrinol 1992;8:213-23.
34. Kyle AH, Huxham LA, Baker JH, Burston HE, Minchinton AI. Tumor distribution of bromodeoxyuridine-labeled cells is strongly dose dependent. Cancer Res 2003;63:5707-11. (Pubitemid 37187464)
35. Minchinton AI, Wendt KR, Clow KA, Fryer KH. Multilayers of cells growing on a permeable support: An in vitro tumour model. Acta Oncologica 1997;36:13-6. (Pubitemid 27135154)
36. Reinhold WC, Reimers MA, Lorenzi P, Ho J, Shankavaram UT, Ziegler MS, et al. Multifactorial regulation of E-cadherin expression: an integrative study. Mol Cancer Ther 2010;9:1-16.
37. Yang L, Li J, Ran L, Pan F, Zhao X, Ding Z, et al. Phosphorylated insulin-like growth factor 1 receptor is implicated in resistance to the cytostatic effect of gefitinib in colorectal cancer cells. J Gastrointest Surg 2011;15:942-57.
38. Cowan DSM, Hicks KO, Wilson WR. Multicellular membranes as an in vitro model for extravascular diffusion in tumours. Br J Cancer 1996;74:S28-31. (Pubitemid 26237922)
39. Vaupel P, Okunieff P, Neuringer LJ. Blood flow, tissue oxygenation, pH distribution, and energy metabolism of murine mammary adenocarcinomas during growth. Adv Exp Med Biol 1989;248:835-45.
40. Hill GB, Osterhout S, O'Fallon WM. Variation in response to hyperbaric oxygen among inbred strains of mice. Proc Soc Exp Biol Med 1968;129:687-9.
41. Bean JW. Hyperbaric oxygenation. Factors influencing clinical oxygen toxicity. Ann N Y Acad Sci 1965;117:745-59.